US2020332320A1PendingUtilityA1

Microorganisms and processes for producing terephthalic acid and its salts

Assignee: GENOMATICA INCPriority: Jan 20, 2012Filed: May 4, 2020Published: Oct 22, 2020
Est. expiryJan 20, 2032(~5.5 yrs left)· nominal 20-yr term from priority
C12P 7/44C08G 63/183C12N 9/0004C12N 9/1205C12N 9/1007C12N 9/88C07F 9/091C12N 9/1085C07C 51/43C12P 7/40C12N 9/0008C12N 9/1022C12N 9/0006C12P 9/00C12P 7/24C12P 7/62
67
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

The invention provides non-naturally occurring microbial organisms having a (2-hydroxy-3-methyl-4-oxobutoxy)phosphonate (2H3M4OP) pathway, p-toluate pathway, and/or terephthalate pathway. The invention additionally provides methods of using such organisms to produce 2H3M4OP, p-toluate or terephthalate. Also provided herein are processes for isolating bio-based aromatic carboxylic acid, in particular, p-toluic acid or terephthalic acid, from a culture medium, wherein the processes involve contacting the culture medium with sufficient carbon dioxide (CO2) to lower the pH of the culture medium to produce a precipitate comprised of the aromatic carboxylic acid.

Claims

exact text as granted — not AI-modified
What is claimed is: 
     
         1 . A non-naturally occurring microbial organism, said microbial organism having a (2-hydroxy-3-methyl-4-oxobutoxy)phosphonate (2H3M4OP) pathway a p-toluate pathway and a terephthalate pathway and comprising at least one exogenous nucleic acid encoding a 2H3M4OP pathway enzyme expressed in a sufficient amount to produce 2H3M4OP, wherein said 2H3M4OP pathway comprises a pathway selected from:
 (1) 1A, 1B, 1C, 1D, 1E and 1F;   (2) 2A, 2B and 2C; and   (3) 2D, 2E and 2C,   wherein 1A is an erythrose-4-phosphate dehydrogenase, wherein 1B is a 4-phosphoerythronate dehydrogenase, wherein 1C is a 2-acetyl-2,3-dihydroxy-4-phosphobutanoate synthase, wherein 1D is a 2-acetyl-2,3-dihydroxy-4-phosphobutanoate reductoisomerase, wherein 1E is a 2,3,4-trihydroxy-3-methyl-5-phosphopentanoate dehydratase, wherein 1F is a 4-hydroxy-3-methyl-2-oxo-5-phosphopentanoate decarboxylase, wherein 2A is a 4,5-dihydroxy-2-oxopentanoate methyltransferase, wherein 2B is a 4,5-dihydroxy-3-methyl-2-oxopentanoate kinase, wherein 2C is a 4-hydroxy-3-methyl-2-oxo-5-phosphopentanoate decarboxylase, wherein 2D is a 4,5-dihydroxy-2-oxopentanoate kinase, wherein 2E is a 4-hydroxy-2-oxo-5-phosphopentanoate methyltransferase,   wherein said p-toluate pathway comprises at least one exogenous nucleic acid encoding a p-toluate pathway enzyme expressed in a sufficient amount to produce p-toluate, wherein said p-toluate pathway comprises 4A, 4B, 4C, 4D, 4E, 4F, 4G and 4H, wherein 4A is a 2-dehydro-3-deoxyphosphoheptonate synthase; wherein 4B is a 3-dehydroquinate synthase; wherein 4C is a 3-dehydroquinate dehydratase; wherein 4D is a shikimate dehydrogenase; wherein 4E is a shikimate kinase; wherein 4F is a 3-phosphoshikimate-2-carboxyvinyltransferase; wherein 4G is a chorismate synthase and wherein 4H is a chorismate lyase; and   wherein said microbial organism has a terephthalate pathway and comprises at least one exogenous nucleic acid encoding a terephthalate pathway enzyme expressed in a sufficient amount to produce terephthalate, wherein said terephthalate pathway comprises 5A, 5B and 5C, wherein 5A is a p-toluate methyl-monooxygenase reductase, wherein 5B is a 4-carboxybenzyl alcohol dehydrogenase and wherein 5C is a 4-carboxybenzyl aldehyde dehydrogenase.   
     
     
         2 . The non-naturally occurring microbial organism of  claim 1 , wherein said microbial organism comprises two, three, four, five or six exogenous nucleic acids each encoding at least one enzyme from a 2H3M4OP, a p-toluate or a terephthalate pathway enzyme. 
     
     
         3 . The non-naturally occurring microbial organism of  claim 2 , wherein said microbial organism comprises exogenous nucleic acids encoding each of the enzymes of at least one of the pathways selected from the 2H3M4OP (1)-(3). 
     
     
         4 . The non-naturally occurring microbial organism of  claim 1 , wherein said exogenous nucleic acid is a heterologous nucleic acid. 
     
     
         5 . The non-naturally occurring microbial organism of  claim 1 , wherein said non-naturally occurring microbial organism is in a substantially anaerobic culture medium. 
     
     
         6 . The non-naturally occurring microbial organism of  claim 1 , wherein said microbial organism is a species of bacteria, yeast or fungus. 
     
     
         7 . Culture medium comprising bio-based terephthalate, wherein said culture medium is separated from said microbial organism of  claim 1 . 
     
     
         8 . A composition comprising bio-based terephthalate and a compound other than said bio-based terephthalate, wherein said compound is a trace amount of a cellular portion of said microbial organism of  claim 1 . 
     
     
         9 . A process for isolating a bio-based aromatic carboxylic acid from a culture medium comprising:
 a) culturing a non-naturally occurring microbial organism in a culture medium to produce an aromatic carboxylate anion at a pH sufficient to maintain the aromatic carboxylate anion in soluble form;   b) separating the culture medium from non-soluble materials;   c) contacting the culture medium with sufficient carbon dioxide (CO 2 ) to lower the pH of the culture medium to produce an aromatic carboxylic acid precipitate, wherein the culture medium is substantially depleted of the aromatic carboxylate anion; and   d) separating the aromatic carboxylic acid from the culture medium;   wherein the aromatic carboxylic acid is p-toluic acid or terephthalic acid.   
     
     
         10 . A process for obtaining a bio-derived polymer using said bio-based terephthalate produced by the non-naturally occurring microbial organism of  claim 1 . 
     
     
         11 . The bio-derived polymer of  claim 10 , where said polymer is polyethylene terephthalate (PET), polybutyl terephthalate (PBT), or polytrimethylene terephthalate (PTT).

Join the waitlist — get patent alerts

Track US2020332320A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.